Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory ...
A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed ...
Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical ...
March is national tick awareness month in Canada, and the timing couldn’t be better (or worse, depending on how you look at ...
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...
If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...
Despite the study missing its primary endpoint, Pfizer will continue with the regulatory submission of the vaccine.
An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday; ...
Presented by Alliance for Aging Research{beacon} Health Care Health Care PRESENTED BY The Big Story Pfizer’s Lyme disease ...
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced topline results from the Phase 3 ...
An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...
There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot due to a lack of demand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results